Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases. Worldwide, there are over 1.3 million deaths a year from lung cancer, the leading cause of cancer death in the industrialized world. Allegro Diagnostics was founded in 2006 by Jerome Brody, MD and Avrum Spira, MD, MSc, thought leaders in the fields of pulmonology and genomics, and faculty at the Boston University School of Medicine.
Who We Are
Allegro Diagnostics Vision
The vision of Allegro Diagnostics is to be the global leader in diagnosing epithelial diseases by providing earlier, more accurate information to clinicians and patients about patient health.